US20030203485A1 - Hydrogel thin film containing extracellular matrix components - Google Patents

Hydrogel thin film containing extracellular matrix components Download PDF

Info

Publication number
US20030203485A1
US20030203485A1 US10/419,932 US41993203A US2003203485A1 US 20030203485 A1 US20030203485 A1 US 20030203485A1 US 41993203 A US41993203 A US 41993203A US 2003203485 A1 US2003203485 A1 US 2003203485A1
Authority
US
United States
Prior art keywords
thin film
extracellular matrix
matrix components
hydrogel thin
film containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/419,932
Inventor
Toshiaki Takezawa
Katsutoshi Yoshizato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/419,932 priority Critical patent/US20030203485A1/en
Publication of US20030203485A1 publication Critical patent/US20030203485A1/en
Priority to US11/035,954 priority patent/US7195912B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/044—Collagen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Definitions

  • the present invention relates to a hydrogel thin film containing an extracellular matrix components. More particularly, the present invention relates to a novel hydrogel thin film containing an extracellular matrix components, which is useful for a cell culture substratum and prevention of organ adhesion, has an appropriate elastic strength, can be easily prepared and can be used simply.
  • a method using an extracellular matrix components such as collagen is known as a method for cell culture.
  • various trial efforts have been made to ensure a three-dimensionality as closest as possible to forms of biological tissues or functional expression by alleviating restrictions imposed as a two-dimensional planar culture for ordinary cell culture.
  • the present inventors have carried out studies from various points of view regarding utilization of an extracellular matrix components such as collagen.
  • the object of these studies was to improve the conventional culturing method, and to achieve a method for using a new matrix substance, which would permit easier preparation of a cell culture substratum, be simply applicable, provide satisfactory Performance as a culture substratum, and be applicable also for preventing organ adhesion.
  • the present invention provides a hydrogel thin film containing an extracellular matrix components, which is a thin film comprising a hydrate of a vitrified matrix gel containing an extracellular matrix components (claim 1).
  • the hydrogel thin film contains a plurality of extracellular matrix components (claim 2), wherein the extracellular matrix components is collagen (claim 3), wherein the hydrogel thin film has a cell culture medium components (claim 4), and wherein the thin film is integrated with a retainer (claim 5).
  • the retainer is an annular or a mesh shape (claim 6), wherein the retainer comprises a biological absorbing substance(S) (claim 7), and wherein the retainer has a circular opening which comprises a cylinder retaining and integrating the thin film (claim 8).
  • the present invention provides also a glass-like substance of a dried gel containing an extracellular matrix components as a precursor of the foregoing hydrogel thin film containing an extracellular matrix components.
  • the present invention further provides, regarding the foregoing hydrogel thin film containing an extracellular matrix components, a method comprising the steps of preparing the gel from a solution containing the extracellular matrix components, drying the resultant gel for vitrification thereof, and hydrating the vitrified gel (claim 10), and a method in which a hydrogel thin film containing an extracellular matrix components is used as the cell culture substratum (claim 15).
  • the present invention further provides a method of culturing cells using the foregoing substratum.
  • FIG. 1 shows a phase-contrast microphotograph illustrating the surface of a collagen hydrogel thin film as a reference
  • FIG. 2 shows a perspective view illustrating a circular wire serving as a retainer
  • FIG. 3 shows a photograph showing a collagen hydrogel thin film substratum integrated with a circular wire retainer
  • FIG. 4 shows a photograph showing a collagen hydrogel thin film embedded gauze
  • FIG. 5 shows a process diagram illustrating preparation of the substratum of the present invention using a cylinder as the retainer
  • FIG. 6 shows a microphotograph showing formation of a colony for MEC
  • FIG. 7 shows a microphotograph showing the case of HDF.
  • the hydrogel thin film containing an extracellular matrix components of the present invention as the thin film itself and as that integrated with the retainer, has an appropriate elastic strength and a thin film shape permitting easy handling, and enables achievement of a biochemical composition as a cell culture substratum, thus providing easy preparation for culturing and an excellent expediency.
  • Collagen is a representative extracellular matrix components and its application is attracting the general attention.
  • Applicable extracellular matrix components other than collagen include fibronectin, vitronectin, laminin, proteoglycan, glycosaminoglycan, and MATRIGEL (brand name), and may appropriately be used.
  • An annulus made of a wire or a metal line, or a mesh comprising gauze or other woven stuff may be appropriately used as a retainer.
  • a biological absorbing substance may also be applicable. It suffices to select a shape, a size and a material in response to the manner of use.
  • the retainer may be a cylinder having a circular opening, or a container as a precursor thereof.
  • Manufacture of a cell culture substratum comprises the steps of first mixing an aqueous solution of a matrix such as collagen with a composition having a medium or serum, placing any of various retainers as described above into this mixed solution, and incubating it at a suitable temperature for its gelation.
  • the resultant gel is vitrified by drying by air for example.
  • This vitrification phenomenon, utilization of the thus vitrified gel after further modification, and use of the modified gel after vitrification as a cell culture substratum are not known, but disclosed for the first time in the present invention.
  • the vitrified gel containing an extracellular matrix components such as collagen is hydrated.
  • This provides a hydrogel thin film containing an extracellular matrix components having a satisfactory elastic strength, which serves as a cell culture substratum and is useful for preventing organ adhesion.
  • vitrification in the present invention, it is the general practice to slowly and completely dry the gel containing the extracellular matrix components having a terminal concentration in an aseptic manner (for example, through aseptic air drying), thereby vitrifying the gel. Hydration of the vitrified gel can easily be effected by treating it by PBS, for example.
  • aqueous type-I collagen solution (CELLGEN I-AC or I-PC, made by Koken Company) was added into the tube and uniformly mixed. After placing 2 ml of the mixed collagen solution having a final concentration of 0.24% in a culture dish made of hydrophobic Polystyrene ( ⁇ 35 mm; Falcon #1008), the solution was held in a humidified incubator at 37° C. in the presence of 5% CO 2/ 95% air in 3 hours for its gelation. This collagen gel of the final concentration of 0.24% was vitrified by completely air-drying slowly in an aseptic manner in the covered dish. The vitrified collagen gel was hydrated by adding 2 ml of PBS.
  • the collagen gel thus hydrated was rinsed with 2 ml of PBS several times.
  • the hydrated collagen gel was peeled off from the dish and collected by tracing the inner wall of the dish with a sharp-end pincette along the periphery, in the form of a thin-film collagen hydrogel having a satisfactory elastic strength, as shown in the phase-contrast microphotograph in FIG. 1.
  • a circular retainer ( 1 ) with a knob as shown in FIG. 2 was made with a stainless steel wire (size:#20; 0.9 mm), and 2 ml of the mixed collagen solution having a final concentration of 0.24% prepared in Example 1 was placed, together with this wire retainer, into a hydrophobic polystyrene culture dish ( ⁇ 35 mm; Falcon #1008).
  • the colagen solution with the retainer was vitrified ater its glation.
  • the vitrified collagen gel was hydrated by adding 2 ml PBS. Further, the collagen gel thus hydrated was rinsed several times with 2 ml of PBS.
  • the hydrated collagen gel could be peeled off and collected from the dish by slowly lifting the stainless steel knob, in the form of a thin-film collagen hydrogel having a satisfactory elastic strength with a wire retainer surround it as shown in FIG. 3.
  • a sterilized type-III gauze as prescribed in the Japanese Pharmacopoeia (K-Pine made by, Kawamoto Hotai Zairyou Company) was cut in a circular shape with a knob in an aseptic manner, and immersed the cut gauze in a cell culture medium (Dulbecco's Modified Eagle Medium containing 10% fetal bovine serum, 20 mM HEPES, 100 units/ml penicillin and 100 ⁇ g/ml streptomycin).
  • the gauze was put, together with 5 ml of the mixed collagen solution having a final concentration of 0.24% prepared in Example 1, in a hydrophobic polystyrene culture dish ( ⁇ 60 mm; Falcon #1007).
  • the collagen solution with the gauze was vitrified after its gelation.
  • the vitrified collagen gel was hydrated by adding PBS in the same manner as in Example 1.
  • the hydrated collagen gel could be peeled off-and collected from the dish by slowly lifting the knob of the gauze, in the form of a thin-film collagen hydrogel having a satisfactory elastic strength embedding the gauze as a whole as shown in FIG. A.
  • a sterilized conical tube having an inner volume. of 50 ml (Falcon #2070) was cut to prepare a cylindrical appliance ( 10 ) capable of fixing a collagen hydrogel thin-film as a cell culture substratum as shown in FIG. 5 ( a).
  • Example 4 10ml of the cell culture medium was placed in a hydrophilic polystyrene culture dish ( ⁇ 60 mm; Falcon #3002) , and the collagen hydrogel fixed onto the appliance in Example 4 was put into the dish. 2 ml of the cell suspension (3 ⁇ 10 4 /ml) was seeded in the interior of the appliance and cultured in a humidified incubator at 37° C. in the presence of 5% CO 2 95% air. Human dermal fibroblasts (HDF) and human cholangio-adenocarcinoma cell line (MEC) were used as cells. After culturing the cells for five days, the cells were fixed with formalin and stained directly with hema-toxylineosin (HE).
  • HDF human dermal fibroblasts
  • MEC human cholangio-adenocarcinoma cell line
  • the present invention is not limited in any manner by the examples shown above.
  • Various embodiments are Possible as to cells capable of being cultured, composition of culture medium, and culturing conditions as well as kinds of an extracellular matrix components such as a collagen hydrogel thin film, composition of substratum, thickness and elastic strength of the thin film.
  • a culture substratum and an organ adhesion preventive substance of a hydrogel thin film containing an extracellular matrix components such as collagen which can be easily prepared and provides an excellent expediency.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The thin film of the invention comprises a hydrate of a vitrified gel containing an extracellular matrix components, which can be integrated with a retainer as required. A hydrogel thin film containing an extracellular matrix components such as thin-film collagen hydrogel thin film, which is useful for a cell culture substratum and for preventing organ adhesion, can be easily prepared, and is excellent in expediency.

Description

    FIELD OF THE INVENTION
  • The present invention relates to a hydrogel thin film containing an extracellular matrix components. More particularly, the present invention relates to a novel hydrogel thin film containing an extracellular matrix components, which is useful for a cell culture substratum and prevention of organ adhesion, has an appropriate elastic strength, can be easily prepared and can be used simply. [0001]
    • PRIOR ART AND PROBLEMS
  • Cell culture has conventionally been carried out in various manners for various purposes including development of various medical techniques and various medical drugs. [0002]
  • A method using an extracellular matrix components such as collagen is known as a method for cell culture. In this method, in the case of collagen for example, various trial efforts have been made to ensure a three-dimensionality as closest as possible to forms of biological tissues or functional expression by alleviating restrictions imposed as a two-dimensional planar culture for ordinary cell culture. [0003]
  • Regarding the culturing methods using collagen or the like attracting the general attention as to usage thereof, however, in the case of collagen hydrogel for example, there is a problem of difficulty in handling the collagen hydrogel itself because of the softness. It is not therefore easy to prepare a cell culture substratum, and a more simple method for utilization has not as yet been established. [0004]
  • Under such circumstances, the present inventors have carried out studies from various points of view regarding utilization of an extracellular matrix components such as collagen. The object of these studies was to improve the conventional culturing method, and to achieve a method for using a new matrix substance, which would permit easier preparation of a cell culture substratum, be simply applicable, provide satisfactory Performance as a culture substratum, and be applicable also for preventing organ adhesion. [0005]
    • SUMMARY OF THE INVENTION
  • As means to solve the foregoing problems, the present invention provides a hydrogel thin film containing an extracellular matrix components, which is a thin film comprising a hydrate of a vitrified matrix gel containing an extracellular matrix components (claim 1). [0006]
  • The present invention provides also embodiments wherein the hydrogel thin film contains a plurality of extracellular matrix components (claim 2), wherein the extracellular matrix components is collagen (claim 3), wherein the hydrogel thin film has a cell culture medium components (claim 4), and wherein the thin film is integrated with a retainer (claim 5). There are provided embodiments of the retainer, wherein the retainer is an annular or a mesh shape (claim 6), wherein the retainer comprises a biological absorbing substance(S) (claim 7), and wherein the retainer has a circular opening which comprises a cylinder retaining and integrating the thin film (claim 8). [0007]
  • The present invention provides also a glass-like substance of a dried gel containing an extracellular matrix components as a precursor of the foregoing hydrogel thin film containing an extracellular matrix components. [0008]
  • The present invention further provides, regarding the foregoing hydrogel thin film containing an extracellular matrix components, a method comprising the steps of preparing the gel from a solution containing the extracellular matrix components, drying the resultant gel for vitrification thereof, and hydrating the vitrified gel (claim 10), and a method in which a hydrogel thin film containing an extracellular matrix components is used as the cell culture substratum (claim 15). [0009]
  • The present invention further provides a method of culturing cells using the foregoing substratum.[0010]
    • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows a phase-contrast microphotograph illustrating the surface of a collagen hydrogel thin film as a reference; [0011]
  • FIG. 2 shows a perspective view illustrating a circular wire serving as a retainer; [0012]
  • FIG. 3 shows a photograph showing a collagen hydrogel thin film substratum integrated with a circular wire retainer; [0013]
  • FIG. 4 shows a photograph showing a collagen hydrogel thin film embedded gauze; [0014]
  • FIG. 5 shows a process diagram illustrating preparation of the substratum of the present invention using a cylinder as the retainer; [0015]
  • FIG. 6 shows a microphotograph showing formation of a colony for MEC; and [0016]
  • FIG. 7 shows a microphotograph showing the case of HDF.[0017]
  • In the drawings, the reference numerals represent the following components:. [0018]
  • [0019] 1: Circular wire retainer
  • [0020] 10: Cylindrical appliance
  • [0021] 11: Circular wire retainer
  • [0022] 12: Collagen hydrogel thin film
  • [0023] 13: Cover
    • DETAILED DESCRIPTION OF THE INVENTION
  • As described above, the hydrogel thin film containing an extracellular matrix components of the present invention, as the thin film itself and as that integrated with the retainer, has an appropriate elastic strength and a thin film shape permitting easy handling, and enables achievement of a biochemical composition as a cell culture substratum, thus providing easy preparation for culturing and an excellent expediency. [0024]
  • Collagen is a representative extracellular matrix components and its application is attracting the general attention. Applicable extracellular matrix components other than collagen include fibronectin, vitronectin, laminin, proteoglycan, glycosaminoglycan, and MATRIGEL (brand name), and may appropriately be used. [0025]
  • There is no particular restriction on the cell culture medium components, and optimum salt composition, concentration and pH are selected. [0026]
  • An annulus made of a wire or a metal line, or a mesh comprising gauze or other woven stuff may be appropriately used as a retainer. A biological absorbing substance may also be applicable. It suffices to select a shape, a size and a material in response to the manner of use. The retainer may be a cylinder having a circular opening, or a container as a precursor thereof. [0027]
  • Manufacture of a cell culture substratum comprises the steps of first mixing an aqueous solution of a matrix such as collagen with a composition having a medium or serum, placing any of various retainers as described above into this mixed solution, and incubating it at a suitable temperature for its gelation. [0028]
  • The resultant gel is vitrified by drying by air for example. This vitrification phenomenon, utilization of the thus vitrified gel after further modification, and use of the modified gel after vitrification as a cell culture substratum are not known, but disclosed for the first time in the present invention. [0029]
  • More particularly, in the manufacturing method of the present invention, the vitrified gel containing an extracellular matrix components such as collagen is hydrated. This provides a hydrogel thin film containing an extracellular matrix components having a satisfactory elastic strength, which serves as a cell culture substratum and is useful for preventing organ adhesion. [0030]
  • For vitrification, in the present invention, it is the general practice to slowly and completely dry the gel containing the extracellular matrix components having a terminal concentration in an aseptic manner (for example, through aseptic air drying), thereby vitrifying the gel. Hydration of the vitrified gel can easily be effected by treating it by PBS, for example. [0031]
  • The construction and the functions of the present invention will now be described below further in detail by means of examples involving collagen. [0032]
    • EXAMPLES Example 1 Preparation of Collagen Hydrogel Thin Film
  • 2 ml of quintuple-concentration Dulbecco's Modified Eagle Medium (GIBCO #31600-034), 0.1 ml of 10,000units/ml penicillin and 10,000 μg/ml streptomycin (GIBCO #15140-031), 0.2 ml of 1M HEPES (GIBCO #15630-023), 0.493 ml of 7.5% sodium bicarbonate solution (GIBCO [0033] #25080-011), 1.407 ml of distilled water, and 1 ml of fetal bovine serum were put in a sterilized conical tube (Falcon #2070) chilled on ice. having an inner volume of 50 ml, and mixed. Then 4.8 ml of 0.5% aqueous type-I collagen solution (CELLGEN I-AC or I-PC, made by Koken Company) was added into the tube and uniformly mixed. After placing 2 ml of the mixed collagen solution having a final concentration of 0.24% in a culture dish made of hydrophobic Polystyrene (φ35 mm; Falcon #1008), the solution was held in a humidified incubator at 37° C. in the presence of 5% CO2/95% air in 3 hours for its gelation. This collagen gel of the final concentration of 0.24% was vitrified by completely air-drying slowly in an aseptic manner in the covered dish. The vitrified collagen gel was hydrated by adding 2 ml of PBS. The collagen gel thus hydrated was rinsed with 2 ml of PBS several times. The hydrated collagen gel was peeled off from the dish and collected by tracing the inner wall of the dish with a sharp-end pincette along the periphery, in the form of a thin-film collagen hydrogel having a satisfactory elastic strength, as shown in the phase-contrast microphotograph in FIG. 1.
    • Example 2 Preparation of Collagen Hydrogel Thin-Film with Peripheral Wire Retainer
  • A circular retainer ([0034] 1) with a knob as shown in FIG. 2 was made with a stainless steel wire (size:#20; 0.9 mm), and 2 ml of the mixed collagen solution having a final concentration of 0.24% prepared in Example 1 was placed, together with this wire retainer, into a hydrophobic polystyrene culture dish (φ35 mm; Falcon #1008). In the same manner as in example 1, the colagen solution with the retainer was vitrified ater its glation. The vitrified collagen gel was hydrated by adding 2 ml PBS. Further, the collagen gel thus hydrated was rinsed several times with 2 ml of PBS. The hydrated collagen gel could be peeled off and collected from the dish by slowly lifting the stainless steel knob, in the form of a thin-film collagen hydrogel having a satisfactory elastic strength with a wire retainer surround it as shown in FIG. 3.
    • Example 3 Preparation of Gauze Embedding Type Collagen Hydrogel Thin Film
  • A sterilized type-III gauze as prescribed in the Japanese Pharmacopoeia (K-Pine made by, Kawamoto Hotai Zairyou Company) was cut in a circular shape with a knob in an aseptic manner, and immersed the cut gauze in a cell culture medium (Dulbecco's Modified Eagle Medium containing 10% fetal bovine serum, 20 mM HEPES, 100 units/ml penicillin and 100 μg/ml streptomycin). The gauze was put, together with 5 ml of the mixed collagen solution having a final concentration of 0.24% prepared in Example 1, in a hydrophobic polystyrene culture dish (φ60 mm; Falcon #1007). In the same manner as in example 1, the collagen solution with the gauze was vitrified after its gelation. [0035]
  • Furthermore, the vitrified collagen gel was hydrated by adding PBS in the same manner as in Example 1. The hydrated collagen gel could be peeled off-and collected from the dish by slowly lifting the knob of the gauze, in the form of a thin-film collagen hydrogel having a satisfactory elastic strength embedding the gauze as a whole as shown in FIG. A. [0036]
    • Example 4 Preparation Cylinder-Retained Collagen Hydrogel Thin-Film
  • A sterilized conical tube having an inner volume. of 50 ml (Falcon #2070) was cut to prepare a cylindrical appliance ([0037] 10) capable of fixing a collagen hydrogel thin-film as a cell culture substratum as shown in FIG. 5 (a).
  • By the use of a collagen hydrogel thin film ([0038] 12) with a wire peripheral retainer (11) prepared in Example 2, the cover (13) prepared from the conical tube was pressed as shown in FIG. 5 (b), and then the wire retainer (11) was removed. By doing so, it was possible to transfer and fix easily the collagen hydrogel thin film onto an opening of the appliance (10). In this state, the resultant product could be used for cell culture. The gauze embedding type collagen hydrogel thin film shown in Example 3 could be fixed onto the appliance in the same manner as above.
    • Example 5 Cell Culture on Collagen Hydrogel Thin Film
  • 10ml of the cell culture medium was placed in a hydrophilic polystyrene culture dish (φ60 mm; Falcon #3002) , and the collagen hydrogel fixed onto the appliance in Example 4 was put into the dish. 2 ml of the cell suspension (3×10[0039] 4/ml) was seeded in the interior of the appliance and cultured in a humidified incubator at 37° C. in the presence of 5% CO295% air. Human dermal fibroblasts (HDF) and human cholangio-adenocarcinoma cell line (MEC) were used as cells. After culturing the cells for five days, the cells were fixed with formalin and stained directly with hema-toxylineosin (HE). In the case of MEC, the cells formed several colonies on the collagen hydrogel thin film as shown in the photograph) in FIG. 6. In the case of HDF, some cells seemed to invade-the collagen hydrogel thin film (photo in FIG. 7). A frozen cross-section of the gel was therefore prepared and subjected to HE staining: while MEC showed no invasion into the gel, HDF revealed an apparent invasion into the gel.
  • It is needless to mention that the present invention is not limited in any manner by the examples shown above. Various embodiments are Possible as to cells capable of being cultured, composition of culture medium, and culturing conditions as well as kinds of an extracellular matrix components such as a collagen hydrogel thin film, composition of substratum, thickness and elastic strength of the thin film. [0040]
  • According to the present invention, as described above in detail, there are available a culture substratum and an organ adhesion preventive substance of a hydrogel thin film containing an extracellular matrix components such as collagen, which can be easily prepared and provides an excellent expediency. [0041]

Claims (17)

What is claimed is:
1. A hydrogel thin film containing an extracellular matrix components, which is a thin film comprising a hydrate of a vitrified matrix gel containing an extracellular matrix components.
2. A hydrogel thin film containing an extracellular matrix components as claimed in claim 1, wherein said hydrogel thin film contains a plurality of extracellular matrix components.
3. A hydrogel thin film containing an extracellular matrix components as claimed in claim 1 or 2, wherein said an extracellular matrix components is collagen.
4. A hydrogel thin film containing an extracellular matrix components as claimed in any one of claims 1 to 3, wherein said hydrogel thin film has a cell culture medium components
5. A hydrogel thin film containing an extracellular matrix components as claimed in any one of claims 1 to 4, wherein said thin film is integrated with a retainer.
6. A hydrogel thin film containing an extracellular matrix components as claimed in claim 5, wherein said retainer is an annular or a mesh shape.
7. A hydrogel thin film containing an extracellular matrix components as claimed in claim 5 or 6, wherein said retainer comprises a biological absorbing substance(s).
8. A hydrogel thin film containing an extracellular matrix components as claimed in claim 5, wherein said retainer has a circular opening which comprises a cylinder retaining and integrating the thin film.
9. A glass-like substance of a dried gel containing an extracellular matrix components, which comprises a dried gel containing an extracellular matrix component(s) as claimed in any one of claims 1 to 7.
10. A method of manufacturing a hydrogel thin film containing an extracellular matrix components, which comprises the steps of preparing the gel from a solution containing the extracellular matrix component(s), drying the resultant gel for vitrification thereof, and then hydrating the vitrified gel.
11. A method of manufacturing a hydrogel thin film containing an extracellular matrix components as claimed in claim 10, wherein said hydrogel thin film contains a plurality of extracellular matrix components.
12. A method of manufacturing a hydrogel thin film containing an extracellular matrix components as claimed in claim 10 or 11, wherein said an extracellular matrix components is collagen.
13. A method of manufacturing a hydrogel thin film containing an extracellular matrix components as claimed in any one of claims 10 to 12, wherein said thin film has a cell culture medium components.
14. A method of manufacturing a hydrogel thin film containing an extracellular matrix components as claimed in any one of claims 10 to 13, wherein the thin film is integrated with a retainer, which is prepared by gelation in the presence of said retainer and hydrating the vitrified gel after drying and vitrification.
15. A method of manufacturing a hydrogel thin film containing an extracellular matrix components as claimed in claim 14, which is integrated with a cylinder, wherein said thin film retained integrally with said cyclic retainer manufactured by said method of claim 14 is fixed by the transfer onto the cylinder having a circular opening having a diameter smaller than said cyclic retainer.
16. A cell culture substratum which comprises the thin film as claimed in any one of claims 1 to 8.
17. A cell culturing method using a hydrogel thin film containing an extracellular matrix components, which comprises the step of seeding and culturing cells on the substratum according to claim 16.
US10/419,932 1997-09-09 2003-04-22 Hydrogel thin film containing extracellular matrix components Abandoned US20030203485A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/419,932 US20030203485A1 (en) 1997-09-09 2003-04-22 Hydrogel thin film containing extracellular matrix components
US11/035,954 US7195912B2 (en) 1997-09-09 2005-01-18 Hydrogel thin film containing extracellular matrix components

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92568297A 1997-09-09 1997-09-09
US10/084,426 US20020086423A1 (en) 1997-09-09 2002-02-28 Hydrogel thin film containing extracellular matrix components
US10/419,932 US20030203485A1 (en) 1997-09-09 2003-04-22 Hydrogel thin film containing extracellular matrix components

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/084,426 Continuation US20020086423A1 (en) 1997-09-09 2002-02-28 Hydrogel thin film containing extracellular matrix components

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/035,954 Division US7195912B2 (en) 1997-09-09 2005-01-18 Hydrogel thin film containing extracellular matrix components

Publications (1)

Publication Number Publication Date
US20030203485A1 true US20030203485A1 (en) 2003-10-30

Family

ID=25452085

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/084,426 Abandoned US20020086423A1 (en) 1997-09-09 2002-02-28 Hydrogel thin film containing extracellular matrix components
US10/419,932 Abandoned US20030203485A1 (en) 1997-09-09 2003-04-22 Hydrogel thin film containing extracellular matrix components
US11/035,954 Expired - Fee Related US7195912B2 (en) 1997-09-09 2005-01-18 Hydrogel thin film containing extracellular matrix components

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/084,426 Abandoned US20020086423A1 (en) 1997-09-09 2002-02-28 Hydrogel thin film containing extracellular matrix components

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/035,954 Expired - Fee Related US7195912B2 (en) 1997-09-09 2005-01-18 Hydrogel thin film containing extracellular matrix components

Country Status (1)

Country Link
US (3) US20020086423A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130280807A1 (en) * 2010-11-12 2013-10-24 Toshiaki Takezawa Cell culture chamber, method for producing same, tissue model using cell culture chamber, and method for producing same
US20140024117A1 (en) * 2012-07-12 2014-01-23 Board Of Regents, The University Of Texas System Extracellular Matrix Films And Methods Of Making And Using Same
US10052400B2 (en) 2014-05-30 2018-08-21 Sofradim Production Method for preparing neutralized matrix of non-antigenic collagenous material
US10549015B2 (en) 2014-09-24 2020-02-04 Sofradim Production Method for preparing an anti-adhesion barrier film

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599526B2 (en) * 2000-08-18 2003-07-29 The University Of North Texas Health Science Center At Fort Worth Pericardial anti-adhesion patch
US6770721B1 (en) * 2000-11-02 2004-08-03 Surface Logix, Inc. Polymer gel contact masks and methods and molds for making same
JP3603103B2 (en) * 2000-11-15 2004-12-22 独立行政法人農業・生物系特定産業技術研究機構 Co-culture carrier for fertilized eggs of animals (excluding humans) and method for culturing fertilized eggs of animals (excluding humans) using this carrier
CA2388723C (en) * 2001-06-06 2012-10-23 Becton, Dickinson & Company Method of providing a substrate with a ready-to-use, uniformly distributed extracellular matrix
EP1477119A4 (en) * 2002-02-20 2009-06-10 Next21 Kk Drug administration method
CA2556422A1 (en) 2004-02-17 2005-08-01 Cook Biotech Incorporated Medical devices and methods for applying bolster material
WO2008001952A1 (en) 2006-06-30 2008-01-03 Kyoto University Thin film multilocular structure comprising collagen, material for tissue regeneration containing the same and method for producing the same
JP5214223B2 (en) * 2007-11-15 2013-06-19 船井電機株式会社 projector
WO2012026531A1 (en) * 2010-08-25 2012-03-01 独立行政法人農業生物資源研究所 Dried hydrogel, dried vitrigel film, and processes for producing these
US9211256B2 (en) 2011-03-08 2015-12-15 The Johns Hopkins University Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof
US8871016B2 (en) 2011-08-03 2014-10-28 The Johns Hopkins University Cellulose-based hydrogels and methods of making thereof
US9175153B2 (en) 2011-03-08 2015-11-03 The Johns Hopkins University Cellulose hydrogel compositions and contact lenses for corneal applications
US9005289B1 (en) 2011-07-01 2015-04-14 Clemson University Tissue engineered nucleus pulposus replacement
WO2015164733A1 (en) * 2014-04-25 2015-10-29 The Johns Hopkins University Compositions comprising cyclodextrin incorporated collagen matrices for use in biomedical applications
EP3347065B1 (en) 2015-09-08 2022-06-29 Clemson University Decellularized biomaterial and method for formation
EP3347062B1 (en) 2015-09-08 2021-12-15 Clemson University Multi-layered biomimetic material and method of formation
WO2019033096A1 (en) 2017-08-11 2019-02-14 The Trustees Of The University Of Pennsylvania Native extracellular matrix-derived membrane inserts for organs on chips, multilayer microfluidics microdevices, and three-dimensional cell culture systems

Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388428A (en) * 1981-07-20 1983-06-14 National Patent Development Corporation Biologically stabilized compositions comprising collagen as the major component with ethylenically unsaturated compounds used as contact lenses
US4570629A (en) * 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
US4612012A (en) * 1982-07-28 1986-09-16 White Thomas C Corneal implant
US4983181A (en) * 1986-10-16 1991-01-08 Cbs Lens, Collagen hydrogel for promoting epithelial cell growth and artificial lens using the same
US5015584A (en) * 1987-10-14 1991-05-14 Board Of Regents, The University Of Texas System Epidermal graft system
US5106743A (en) * 1981-01-26 1992-04-21 Trustees Of Boston University Hydrogels capable of supporting cell growth
US5106949A (en) * 1989-09-15 1992-04-21 Organogenesis, Inc. Collagen compositions and methods for preparation thereof
US5108428A (en) * 1988-03-02 1992-04-28 Minnesota Mining And Manufacturing Company Corneal implants and manufacture and use thereof
US5206028A (en) * 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
US5336501A (en) * 1989-02-08 1994-08-09 Lohmann Gmbh & Co. Kg Cross-linked hydrogels and their use as wound dressings
US5374515A (en) * 1992-11-13 1994-12-20 Organogenesis, Inc. In vitro cornea equivalent model
US5429590A (en) * 1992-12-01 1995-07-04 Nitto Denko Corporation Medical water-absorptive polymer and dressing for wound and medical bandage using the same
US5431639A (en) * 1993-08-12 1995-07-11 Boston Scientific Corporation Treating wounds caused by medical procedures
US5536656A (en) * 1989-09-15 1996-07-16 Organogenesis, Inc. Preparation of tissue equivalents by contraction of a collagen gel layered on a collagen gel
US5591709A (en) * 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
US5709934A (en) * 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
US5712161A (en) * 1993-12-30 1998-01-27 Nitta Gelatin Inc. Method for culturing animal cells in collagen drops on a support
US5736399A (en) * 1994-03-09 1998-04-07 Research Development Corporation Of Japan Medium-penetrating cell culture carrier, a culturing method and a device using this carrier
US5836313A (en) * 1993-02-08 1998-11-17 Massachusetts Institute Of Technology Methods for making composite hydrogels for corneal prostheses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62266064A (en) 1986-05-14 1987-11-18 株式会社　高研 Production of collagen membrane
JPH08163996A (en) * 1994-12-13 1996-06-25 Sumitomo Bakelite Co Ltd Animal cytotoxicity test method
JP3081130B2 (en) 1995-02-23 2000-08-28 科学技術振興事業団 Hydrogel thin film containing extracellular matrix component

Patent Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106743A (en) * 1981-01-26 1992-04-21 Trustees Of Boston University Hydrogels capable of supporting cell growth
US4388428A (en) * 1981-07-20 1983-06-14 National Patent Development Corporation Biologically stabilized compositions comprising collagen as the major component with ethylenically unsaturated compounds used as contact lenses
US4570629A (en) * 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
US4612012A (en) * 1982-07-28 1986-09-16 White Thomas C Corneal implant
US4983181A (en) * 1986-10-16 1991-01-08 Cbs Lens, Collagen hydrogel for promoting epithelial cell growth and artificial lens using the same
US5015584A (en) * 1987-10-14 1991-05-14 Board Of Regents, The University Of Texas System Epidermal graft system
US5108428A (en) * 1988-03-02 1992-04-28 Minnesota Mining And Manufacturing Company Corneal implants and manufacture and use thereof
US5336501A (en) * 1989-02-08 1994-08-09 Lohmann Gmbh & Co. Kg Cross-linked hydrogels and their use as wound dressings
US5536656A (en) * 1989-09-15 1996-07-16 Organogenesis, Inc. Preparation of tissue equivalents by contraction of a collagen gel layered on a collagen gel
US5106949A (en) * 1989-09-15 1992-04-21 Organogenesis, Inc. Collagen compositions and methods for preparation thereof
US5206028A (en) * 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
US5591709A (en) * 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
US5374515A (en) * 1992-11-13 1994-12-20 Organogenesis, Inc. In vitro cornea equivalent model
US5429590A (en) * 1992-12-01 1995-07-04 Nitto Denko Corporation Medical water-absorptive polymer and dressing for wound and medical bandage using the same
US5836313A (en) * 1993-02-08 1998-11-17 Massachusetts Institute Of Technology Methods for making composite hydrogels for corneal prostheses
US5431639A (en) * 1993-08-12 1995-07-11 Boston Scientific Corporation Treating wounds caused by medical procedures
US5712161A (en) * 1993-12-30 1998-01-27 Nitta Gelatin Inc. Method for culturing animal cells in collagen drops on a support
US5736399A (en) * 1994-03-09 1998-04-07 Research Development Corporation Of Japan Medium-penetrating cell culture carrier, a culturing method and a device using this carrier
US5709934A (en) * 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130280807A1 (en) * 2010-11-12 2013-10-24 Toshiaki Takezawa Cell culture chamber, method for producing same, tissue model using cell culture chamber, and method for producing same
US20140024117A1 (en) * 2012-07-12 2014-01-23 Board Of Regents, The University Of Texas System Extracellular Matrix Films And Methods Of Making And Using Same
US9644177B2 (en) * 2012-07-12 2017-05-09 Board Of Regents, The University Of Texas System Extracellular matrix films and methods of making and using same
US10052400B2 (en) 2014-05-30 2018-08-21 Sofradim Production Method for preparing neutralized matrix of non-antigenic collagenous material
US10549015B2 (en) 2014-09-24 2020-02-04 Sofradim Production Method for preparing an anti-adhesion barrier film
US12070534B2 (en) 2014-09-24 2024-08-27 Sofradim Production Method for preparing an anti-adhesion barrier film

Also Published As

Publication number Publication date
US20020086423A1 (en) 2002-07-04
US7195912B2 (en) 2007-03-27
US20050129720A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
US7195912B2 (en) Hydrogel thin film containing extracellular matrix components
US5906937A (en) Culture skin and process for preparing the same
EP0418035B1 (en) Living tissue equivalents
US5015584A (en) Epidermal graft system
JP2655269B2 (en) Skin substitute
JP3081130B2 (en) Hydrogel thin film containing extracellular matrix component
US5122470A (en) Floating cell culture device and method
US5480827A (en) Use of porous polycrystalline aragonite as a support material for in vitro culture of cells
JPH07507063A (en) Biotherapeutic cell-coated microspheres
US20050129730A1 (en) Tissue composites and uses thereof
US11180728B2 (en) In-vitro full-skin model containing three-dimensional cell culture models of the sweat gland
WO2002045766A1 (en) Tissue equivalant for transplantation and process for producing the same
JP6835384B1 (en) Cell culture device and its use
WO2005014774A1 (en) Carrier for culturing animal cell, and method for culturing or transplanting animal cell using said carrier for culture
WO1992010217A1 (en) Wound dressings and processes for manufacture thereof
Kalyanaraman et al. Medium flow rate regulates viability and barrier function of engineered skin substitutes in perfusion culture
RU2014359C1 (en) Three-dimensional bioactive carrier for mammalian cells and tissues cultivation
WO2007023645A1 (en) Method of purifying three-dimensional culture and the three-dimensional culture thus purified
EP0907725B1 (en) A process for encapsulating viable animal cells
RU2418067C1 (en) Method of cell cultivation
CA2214812A1 (en) Hydrogel thin film containing extracellular matrix components
WO1997006835A1 (en) Cell culture products
Kuroyanagi et al. Cytotoxicity tests for antimicrobial agents using cultured skin substitutes fixed at interface of air and culture medium
CN111117945B (en) Skin model containing melanin, construction method and application thereof
AU3406000A (en) Cell culture products

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION